Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Expands Indication for Soliqua® 100/33

americanpharmaceuticalreviewMarch 01, 2019

Tag: FDA , medicines , Soliqua® 100/33

PharmaSources Customer Service